This inventor holds 3 USPTO granted patents. Top assignees: Nippon Beet Sugar Manufacturing., Co., Ltd., Nippon Beet Sugar Mfg., Co., Ltd.. Active years: 2011-2012.
Location History:
- Hokkaido, JP (2011)
- Obihiro, JP (2011 - 2012)
Company Filing History:
Years Active: 2011-2012
Title: Norimitsu Takagi: Innovator in Sugar Chemistry
Introduction
Norimitsu Takagi is a notable inventor based in Obihiro, Japan. He has made significant contributions to the field of sugar chemistry, particularly in the production of difructose dianhydride III (DFA III). With a total of 3 patents to his name, Takagi's work has implications for both industrial applications and health.
Latest Patents
Takagi's latest patents focus on a process for producing difructose dianhydride III crystals. This process involves creating an indigestible disaccharide where two fructose molecules are bonded at specific positions. The solutions containing DFA III are adjusted to maintain a pH of 5 or more, preferably between pH 5 to 8. This innovative method allows for industrial production without compromising crystal yield, even in a recycling system. By controlling the total fructose content in mother solutions for crystallization to 5% or less, and adjusting the fructose content to 1% or less, DFA III can be produced more effectively.
Career Highlights
Throughout his career, Takagi has worked with prominent companies in the sugar manufacturing industry, including Nippon Beet Sugar Manufacturing Co., Ltd. and Nippon Beet Sugar Mfg., Co., Ltd. His expertise in sugar chemistry has positioned him as a key figure in the development of new processes and products.
Collaborations
Takagi has collaborated with notable colleagues such as Tsutomu Aritsuka and Hiroto Kikuchi. These partnerships have contributed to the advancement of research and innovation in the field of sugar chemistry.
Conclusion
Norimitsu Takagi's contributions to the production of difructose dianhydride III highlight his innovative spirit and dedication to advancing sugar chemistry. His patents and collaborations reflect a commitment to improving industrial processes and health-related applications.